alexa A Novel Mutation in Exon 6 of the Epsilon-Sarcoglycan G
ISSN: 2161-1041

Hereditary Genetics: Current Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

A Novel Mutation in Exon 6 of the Epsilon-Sarcoglycan Gene in Myoclonus Dystonia Syndrome

Hulya Apaydin1, Gulcin Benbir1*, Laurie Ozelius2 and Sibel Ozekmekci1

1Department of Neurology, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey

2Department of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY, USA

*Corresponding Author:
Gulcin Benbir
Istanbul University Cerrahpasa Faculty of Medicine
Department of Neurology, 34098, Istanbul, Turkey
Tel: +90 (533) 226 37 97
Fax: +90 (212) 632 96 96
E-mail: [email protected]

Received date: January 10, 2012; Accepted date: June 06, 2012; Published date:June 10, 2012

Citation: Apaydin H, Benbir G, Ozelius L, Ozekmekci S (2012) A Novel Mutation in Exon 6 of the Epsilon-Sarcoglycan Gene in Myoclonus Dystonia Syndrome. Hereditary Genet 1:110. doi: 10.4172/2161-1041.1000110

Copyright: © 2012 Apaydin H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Myoclonus-dystonia syndrome (MDS) is a rare hereditary movement disorder characterized by the early onset of myoclonus in the first or second decade of life. The first locus for MDS was mapped to chromosome 7q21 and identified as the epsilon-sarcoglycan (SGCE) gene, and numerous mutations were subsequently identified. We here present the first reported Turkish MDS patient identified with a novel mutation in exon 6 of the SGCE gene, which resulted in truncation of the protein before the transmembrane domain, presumably causing the loss of function either by mislocalization of the protein away from the plasma membrane or through nonsense-mediated decay.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version